Comanche Biopharma
Accessibility Statement
Comanche Biopharma is committed to making this website usable by everyone, including people who use screen readers, keyboard-only navigation, screen magnification, or other assistive technology. We work toward conformance with the Web Content Accessibility Guidelines (WCAG) 2.1, Level AA.
Tools built into this site
Select Accessibility in the bottom-left of any page to adjust the experience. Your choices are stored on your device and applied on every visit.
- Text size control up to 160%
- High-contrast and inverted colour modes
- Underlined links and a hide-images mode
- Readable font and increased text spacing
- Reading guide, reading mask, and read-aloud on hover
- Reduced motion (pauses background video and animation)
- Enhanced focus outlines and a large cursor
- Skip-to-content link for keyboard users
Language
Select Language in the bottom-left to read the site in more than 100 languages. Translations are machine generated; the English version remains the authoritative source for all scientific and regulatory content.
Ongoing work
Accessibility is an ongoing effort. We review new pages and features for keyboard operability, colour contrast, alternative text, and semantic structure, and we correct issues as they are identified.
Report a barrier
If any part of this site prevents you from finding the information you need, please tell us and we will provide the content in an alternative format.
Email info@comanchebiopharma.com
Comanche Biopharma, 50 Beharrell St, Unit B, Concord, MA 01742